EIF2AK3 and cancer: While CREB3L1’s role in cancer is currently controversial—with some studies suggesting that this factor promotes metastasis, and others suggesting it suppresses metastasis18, 19—we resolve this discrepancy by showing that CREB3L1 specifically promotes metastasis in tumors that have activated both PERK signaling and the EMT program.